BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/8/2023 9:38:26 AM | Browse: 346 | Download: 1333
Publication Name World Journal of Clinical Cases
Manuscript ID 85751
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Aggressive variant prostate cancer: A case report and literature review
Manuscript Source Unsolicited Manuscript
All Author List Xiang-Tao Weng, Wen-Li Lin, Qi-Man Pan, Tao-Fen Chen, Si-Yi Li and Chi-Ming Gu
ORCID
Author(s) ORCID Number
Xiang-Tao Weng http://orcid.org/0000-0003-2004-8995
Wen-Li Lin http://orcid.org/0000-0002-2699-4811
Qi-Man Pan http://orcid.org/0000-0002-6119-684X
Tao-Fen Chen http://orcid.org/0000-0003-2106-468X
Si-Yi Li http://orcid.org/0000-0002-9631-7971
Chi-Ming Gu http://orcid.org/0000-0001-6807-9665
Funding Agency and Grant Number
Funding Agency Grant Number
Guangdong Provincial Hospital of Traditional Chinese Medicine 2022KT1166 and 2018KT1635
Guangdong Provincial Bureau of Traditional Chinese Medicine 2021KT1500
Guangzhou Science and Technology Bureau 202201020350
Corresponding Author Chi-Ming Gu, MD, Chief Physician, Department of Urology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, NO. 111 Dade Road, Yuexiu District, Guangzhou 510000, Guangdong Province, China. guchiming@gzucm.edu.cn
Key Words Aggressive variant prostate cancer; Prostate-specific antigen; Carcinoembryonic antigen; Prostate cancer
Core Tip This article reviews the literature and summarizes the characteristics and research progress of the rare clinical subtype, aggressive variant prostate cancer (AVPC), especially the treatment regimen. AVPC has low prostate-specific antigen levels, is hormone refractory, is aggressive, manifests as rare brain and bladder metastases, and has a very poor clinical prognosis. The first-line regimen for AVPC is currently unclear, with platinum-based chemotherapy regimens as the mainstay of intervention at this stage. Liquid biopsy, gene detection and molecular imaging are currently hot research topics that can provide guidance for the clinical treatment of advanced prostate cancer. This report aims to serve as a reference for clinicians.
Publish Date 2023-09-08 09:38
Citation Weng XT, Lin WL, Pan QM, Chen TF, Li SY, Gu CM. Aggressive variant prostate cancer: A case report and literature review. World J Clin Cases 2023; 11(26): 6213-6222
URL https://www.wjgnet.com/2307-8960/full/v11/i26/6213.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i26.6213
Full Article (PDF) WJCC-11-6213-with-cover.pdf
Full Article (Word) WJCC-11-6213.docx